| Complement system part I–molecular mechanisms of activation and regulation NS Merle, SE Church, V Fremeaux-Bacchi, LT Roumenina Frontiers in immunology 6, 134383, 2015 | 1648 | 2015 |
| Complement system part II: role in immunity NS Merle, R Noe, L Halbwachs-Mecarelli, V Fremeaux-Bacchi, ... Frontiers in immunology 6, 136998, 2015 | 1086 | 2015 |
| Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference THJ Goodship, HT Cook, F Fakhouri, FC Fervenza, V Frémeaux-Bacchi, ... Kidney international 91 (3), 539-551, 2017 | 670 | 2017 |
| Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies A Servais, LH Noël, LT Roumenina, M Le Quintrec, S Ngo, ... Kidney international 82 (4), 454-464, 2012 | 604 | 2012 |
| Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations F Fakhouri, L Roumenina, F Provot, M Sallée, S Caillard, L Couzi, M Essig, ... Journal of the American Society of Nephrology 21 (5), 859-867, 2010 | 573 | 2010 |
| Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies J Zuber, F Fakhouri, LT Roumenina, C Loirat, V Frémeaux-Bacchi, ... Nature Reviews Nephrology 8 (11), 643-657, 2012 | 481 | 2012 |
| Endothelium structure and function in kidney health and disease N Jourde-Chiche, F Fakhouri, L Dou, J Bellien, S Burtey, M Frimat, ... Nature Reviews Nephrology 15 (2), 87-108, 2019 | 388 | 2019 |
| Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort JE Salmon, C Heuser, M Triebwasser, MK Liszewski, D Kavanagh, ... PLoS medicine 8 (3), e1001013, 2011 | 336 | 2011 |
| Complement factor H related proteins (CFHRs) C Skerka, Q Chen, V Fremeaux-Bacchi, LT Roumenina Molecular immunology 56 (3), 170-180, 2013 | 294 | 2013 |
| Context-dependent roles of complement in cancer LT Roumenina, MV Daugan, F Petitprez, C Sautès-Fridman, WH Fridman Nature Reviews Cancer 19 (12), 698-715, 2019 | 276 | 2019 |
| Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome M Frimat, F Tabarin, JD Dimitrov, C Poitou, L Halbwachs-Mecarelli, ... Blood, The Journal of the American Society of Hematology 122 (2), 282-292, 2013 | 258 | 2013 |
| Complement alternative pathway acts as a positive feedback amplification of neutrophil activation L Camous, L Roumenina, S Bigot, S Brachemi, V Frémeaux-Bacchi, ... Blood, The Journal of the American Society of Hematology 117 (4), 1340-1349, 2011 | 251 | 2011 |
| C1q and its growing family R Ghai, P Waters, LT Roumenina, M Gadjeva, MS Kojouharova, ... Immunobiology 212 (4-5), 253-266, 2007 | 241 | 2007 |
| Tumor cells hijack macrophage-produced complement C1q to promote tumor growth LT Roumenina, MV Daugan, R Noe, F Petitprez, YA Vano, ... Cancer immunology research 7 (7), 1091-1105, 2019 | 197 | 2019 |
| Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome LT Roumenina, M Jablonski, C Hue, J Blouin, JD Dimitrov, ... Blood, The Journal of the American Society of Hematology 114 (13), 2837-2845, 2009 | 194 | 2009 |
| Alternative complement pathway assessment in patients with atypical HUS LT Roumenina, C Loirat, MA Dragon-Durey, L Halbwachs-Mecarelli, ... Journal of immunological methods 365 (1-2), 8-26, 2011 | 185 | 2011 |
| Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains LT Roumenina, MM Ruseva, A Zlatarova, R Ghai, M Kolev, N Olova, ... Biochemistry 45 (13), 4093-4104, 2006 | 168 | 2006 |
| Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles NS Merle, A Grunenwald, H Rajaratnam, V Gnemmi, M Frimat, ... JCI insight 3 (12), 2018 | 163 | 2018 |
| A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function LT Roumenina, M Frimat, EC Miller, F Provot, MA Dragon-Durey, ... Blood, The Journal of the American Society of Hematology 119 (18), 4182-4191, 2012 | 159 | 2012 |
| B cells and cancer: To B or not to B? WH Fridman, F Petitprez, M Meylan, TWW Chen, CM Sun, LT Roumenina, ... Journal of Experimental Medicine 218 (1), e20200851, 2020 | 140 | 2020 |
Jordan D DimitrovINSERM在 inserm.fr 的电子邮件经过验证
